We are live on ! Find out more
EW

Evoke Wealth Portfolio holdings

AUM $5.57B
1-Year Est. Return 23.85%
This Fund
S&P 500
This Quarter Est. Return
+10.7%
1 Year Est. Return
+23.85%
3 Year Est. Return
+55.14%
5 Year Est. Return
+52.16%
10 Year Est. Return
–
AUM
$1.48B
AUM Growth
+$249M
Cap. Flow
+$122M
Cap. Flow %
8.22%
Top 10 Hldgs %
69.21%
Holding
1,106
New
57
Increased
223
Reduced
136
Closed
52

Top Buys

Rank Stock Value
1
RPAR icon
RPAR Risk Parity ETF
RPAR
+$78.3M
2
PAVE icon
Global X US Infrastructure Development ETF
PAVE
+$13.9M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$12.8M
4
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$7.43M
5
VTV icon
Vanguard Morningstar Value ETF
VTV
+$6.54M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$11.3M
2
VOD icon
Vodafone
VOD
+$10.1M
3
GLD icon
SPDR Gold Trust
GLD
+$4.28M
4
HLF icon
Herbalife
HLF
+$3.88M
5
CVX icon
Chevron
CVX
+$3.51M

Sector Composition

Rank Sector Weight
1 Financials 4.08%
2 Technology 3.32%
3 Communication Services 2.81%
4 Industrials 1.7%
5 Healthcare 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TAP icon
1001
Molson Coors Class B
TAP
$7.76B
$1K ﹤0.01%
17
– –
TDC icon
1002
Teradata
TDC
$2.87B
$1K ﹤0.01%
24
– –
TEF
1003
DELISTED
Telefonica
TEF
$1K ﹤0.01%
251
-14
-5% -$47
TER icon
1004
Teradyne
TER
$58.4B
$1K ﹤0.01%
5
– –
TLK icon
1005
Telkom Indonesia
TLK
$14.4B
$1K ﹤0.01%
37
– –
ULTA icon
1006
Ulta Beauty
ULTA
$21.9B
$1K ﹤0.01%
3
– –
VVV icon
1007
Valvoline
VVV
$4.87B
$1K ﹤0.01%
54
– –
VYX icon
1008
NCR Voyix
VYX
$1.14B
$1K ﹤0.01%
39
– –
WAT icon
1009
Waters Corp
WAT
$36.6B
$1K ﹤0.01%
3
– –
WST icon
1010
West Pharmaceutical
WST
$23.7B
$1K ﹤0.01%
3
– –
XYL icon
1011
Xylem
XYL
$27.3B
$1K ﹤0.01%
13
– –
ZLAB icon
1012
Zai Lab
ZLAB
$2.05B
$1K ﹤0.01%
9
– –
WRK
1013
DELISTED
WestRock Company
WRK
$1K ﹤0.01%
14
– –
ARNC
1014
DELISTED
Arconic Corporation
ARNC
$1K ﹤0.01%
30
– –
CAJ
1015
DELISTED
Canon, Inc.
CAJ
$1K ﹤0.01%
43
– –
ZNH
1016
DELISTED
China Southern Airlines Company Limited
ZNH
$1K ﹤0.01%
27
– –
GBT
1017
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1K ﹤0.01%
32
– –
DRE
1018
DELISTED
Duke Realty Corp.
DRE
$1K ﹤0.01%
22
– –
PTR
1019
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$1K ﹤0.01%
22
– –
JOBS
1020
DELISTED
51job Inc
JOBS
$1K ﹤0.01%
11
– –
SINA
1021
DELISTED
Sina Corp
SINA
$1K ﹤0.01%
16
– –
BMY.RT
1022
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$1K ﹤0.01%
1,074
-280
-21% -$596
CHU
1023
DELISTED
China Unicom (HONG KONG) Limited
CHU
$1K ﹤0.01%
100
– –
CHA
1024
DELISTED
China Telecom Corporation, LTD
CHA
$1K ﹤0.01%
23
– –
ACWV icon
1025
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.31B
– –
-209
Closed -$19K
39 40
41
42 43

Similar funds

PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GVAG
Great Valley Advisor Group Wilmington, Delaware $5.5B AUM 20.56% 1-Year Est. Return

Evoke Wealth's Q4 2020 Portfolio in Review

As of Q4 2020, Evoke Wealth held 1,106 positions worth $1.48B, up 20% from $1.23B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Evoke Wealth deployed $122M of net new capital in Q4 2020, opening 57 new positions and adding to 223 existing holdings. Its largest new stake was Inari Medical, Inc. Common Stock: 72,256 shares worth $6.31M.

By sector, the portfolio is most concentrated in Financials at 4.1% of assets, down from 5.1% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $11.3M trimmed.

  • Evoke Wealth's largest Q4 2020 buy was Inari Medical, Inc. Common Stock: 72,256 shares worth $6.31M.
  • Evoke Wealth added most to RPAR Risk Parity ETF in Q4 2020, an estimated $78.3M increase.
  • Evoke Wealth's biggest Q4 2020 reduction was JPMorgan Chase, cutting an estimated $11.3M.
  • Evoke Wealth fully exited State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q4 2020, selling an estimated $1.4M.
  • Evoke Wealth's ten largest holdings make up 69% of its $1.48B portfolio in Q4 2020.
  • Evoke Wealth opened 57 new positions and closed 52 in Q4 2020.
  • Evoke Wealth's portfolio value rose 20% quarter-over-quarter to $1.48B.

Based on Evoke Wealth's 13F filing for Q4 2020, filed 12 Feb 2021.